Cargando…
Seeding Collaborations to Advance Kinase Science with the GSK Published Kinase Inhibitor Set (PKIS)
To catalyze research on historically untargeted protein kinases, we created the PKIS, an annotated set of 367 small molecule kinase inhibitors. The set has been widely distributed to academic collaborators as an open access tool. It has been used to identify chemical starting points for development...
Autores principales: | Drewry, David H., Willson, Timothy M., Zuercher, William J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435035/ https://www.ncbi.nlm.nih.gov/pubmed/24283969 http://dx.doi.org/10.2174/1568026613666131127160819 |
Ejemplares similares
-
Profile of the GSK Published Protein Kinase Inhibitor Set Across ATP-Dependent and-Independent Luciferases: Implications for Reporter-Gene Assays
por: Dranchak, Patricia, et al.
Publicado: (2013) -
PKIS deep dive yields a chemical starting point for dark kinases and a cell active BRSK2 inhibitor
por: Tamir, Tigist Y., et al.
Publicado: (2020) -
PKIS: computational identification of protein kinases for experimentally discovered protein phosphorylation sites
por: Zou, Liang, et al.
Publicado: (2013) -
Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs)
por: Wild, Markus, et al.
Publicado: (2021) -
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes
por: Matossian, Margarite D., et al.
Publicado: (2017)